Press release
Myelodysplastic Syndromes Market Business Growth Analysis, Trend, Outlook, Share, and Top Companies are Boston Biomedical, AbbVie Inc., Acceleron Pharma, Inc., BerGenBio ASA
Myelodysplastic Syndromes Market
Global myelodysplastic syndromes market is rising gradually with a healthy CAGR of 11.09% in the forecast period of 2019-2026. Increasing geriatric population, growing awareness about the diseases and improving healthcare expenditure are some major drivers for the market growth.
Request Sample of Global Myelodysplastic Syndromes Market 2019 @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-myelodysplastic-syndromes-market
Some of the key players from the complete study are:
Astex Pharmaceuticals,
Otsuka Holdings Co., Ltd.,
TAIHO PHARMACEUTICAL CO., LTD.,
Lupin,
Takeda Pharmaceutical Company Limited,
Onconova Therapeutics,
Helsinn Healthcare SA,
Boehringer Ingelheim International GmbH,
Johnson & Johnson Services, Inc.,
MEI Pharma Inc.,
Aprea Therapeutics,
Boston Biomedical,
AbbVie Inc.,
Acceleron Pharma, Inc.,
BerGenBio ASA,
CELGENE CORPORATION,
Eisai Co., Ltd.,
among others.
Market Definition:
Myelodysplastic syndromes are a rare group of hematological diseases that are caused by formation of abnormal blood-forming cells in the bone marrow. It occurs due to the mutation of one or more genes which controls the development of blood cells. These are also referred as bone marrow failure disorder. In myelodysplastic syndrome the bone marrow fails to produce healthy red blood cells, white blood cells and or platelets. The most common symptoms of myelodysplastic syndromes are fatigue, weakness, shortness of breath, bone pain and others. The symptoms and severity of MDS varies from person to person.
The prevalence of MSD is estimated to be approximately 22 to 45 cases per 100,000 people over the age of 70. This disease occurs slightly more in males than females. MSD can develop in any age group but it mostly affects population over the age of 60 years.
Myelodysplastic Syndromes Market Drivers
Increasing geriatric population which has a tendency of getting effected with myelodysplastic syndrome acts as a market driver
Technological advancements in the sequencing technologies also drives this market growth
Government initiatives for research and development of target specific therapies and favorable reimbursement policies will also boost this market growth in the forecast period
Growing awareness about the diseases associated with MDS is expected to drive the market growth
Myelodysplastic Syndromes Market Restraints
High cost therapies of myelodysplastic syndromes restricts the market growth
Novel treatment options due to the complexity and heterogeneity of can hamper the market growth
Order a Copy of This Research Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-myelodysplastic-syndromes-market
Myelodysplastic Syndromes Market Segmentation:
Myelodysplastic Syndromes Market : By Type
Myelodysplastic Syndrome with Unilineage Dysplasia
Myelodysplastic Syndrome with Multilineage Dysplasia
Myelodysplastic Syndrome with Ring Sideroblasts
Others
Myelodysplastic Syndromes Market : By Diagnosis
Complete Blood Count
Bone Marrow Aspiration and Biopsy
Others
Myelodysplastic Syndromes Market : By Treatment
Medication
Blood Transfusion
Bone Marrow Transplantation
Others
Myelodysplastic Syndromes Market : By Route of Administration
Oral
Injectable
Others
Myelodysplastic Syndromes Market : By End Users
Hospitals
Homecare
Specialty Clinics
Others
Myelodysplastic Syndromes Market : By Distribution Channels
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
Myelodysplastic Syndromes Market : By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Key Developments in the Myelodysplastic Syndromes Market:
In September 2019, Astex Pharmaceuticals received the Orphan Drug designation for the U. S. FDA for ASTX727, a novel oral hypomethylating agent used for treatment of patients with Myelodysplastic Syndromes (including chronic myelomonocytic leukemia). Astex Pharmaceuticals is a subsidiary of Otsuka Holdings Co., Ltd. and TAIHO PHARMACEUTICAL CO., LTD. The grant of this designation to the drug will provide a seven year market exclusivity in the United States, to the company
In November 2018, Lupin received marketing approval from the U. S. FDA for Decitabine, the generic version of dacogen for treatment of patients with myelodysplastic syndrome. This productis available in injectable dosage form and has similar efficacy to dacogen with treated and untreated, de novo and secondary MDS. This approval provides the marketing grant of Otsuka Pharmaceutical Co. Ltd.’s dacogen and increase the market size of Lupin
Myelodysplastic Syndromes Market Competitive Analysis:
Global myelodysplastic syndromes market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of myelodysplastic syndromes market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global myelodysplastic syndromes market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-myelodysplastic-syndromes-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myelodysplastic Syndromes Market Business Growth Analysis, Trend, Outlook, Share, and Top Companies are Boston Biomedical, AbbVie Inc., Acceleron Pharma, Inc., BerGenBio ASA here
News-ID: 2082282 • Views: …
More Releases from Data Bridge Market Research
Wind Turbine Operations and Maintenance Market is estimated to grow at a Potenti …
Industry Analysis
The rise in investment in offshore wind turbines is escalating the growth of wind turbine operations and maintenance market.
Wind turbine operations and maintenance refer to the services of maintaining the smooth working of the wind turbines. Wind energy means a renewable form of energy which is widely available on the surface of earth. The wind energy is generated by the conversion of wind flow into any useful form of…
Warehouse Robotics Market Exceed Valuation of CAGR of 15.25% by 2029
Industry Analysis
Data Bridge Market Research report on warehouse robotics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the demand in the deployment of robotic systems is escalating the growth of warehouse robotics market. Warehouse robotics is referred to as the deployment of robotics in the warehouse to achieve functions including…
Hibiscus Flower Powder Market Size, Share, Trends, Growth, Strategies, Opportuni …
The trustworthy Hibiscus Flower Powder Market study details the key actions taken by the leading companies and brands, including innovations, product launches, mergers, joint ventures, acquisitions, and competitive analysis in the industry. This winning market paper can cover more ground than just market scenarios and main players' pricing comparisons. It's a comprehensive background study of the sector that also estimates the parental market. A top-notch Hibiscus Flower Powder Market research report…
Caffeinated Beverage Market Business Opportunities, Future Industry Trends, Stra …
A crucial source of information, the Caffeinated Beverage Market Research Report provides approaching and current technological and financial aspects of the industry through 2030. For the benefit of readers and end users, all gathered market data is verified and confirmed by industry professionals. With the help of this reliable marketing report, analyzing the actions of major companies and their impact on sales, import, export, revenue, and CAGR numbers becomes simple. The…
More Releases for Myelodysplastic
Myelodysplastic Syndrome Market Global Research and Clinical Analysis 2020
Global Myelodysplastic Syndrome Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Myelodysplastic Syndrome Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more…
Myelodysplastic Syndrome Treatment Market Trends and Prospects by 2025
Myelodysplastic Syndrome Treatment Market: Overview
Myelodysplastic syndrome (MDS) is a blood disorder caused due to the production of abnormal blood cells in bone marrow. Bone marrow failure leads to drop in the number of healthy blood cells in the body. In MDS, bone marrow does not produce healthy red blood cells, white blood cells, and/or platelets. Symptoms of MDS in the beginning are no specific than causes of pancytopenia i.e., deficiency…
Myelodysplastic Syndrome Treatment to worth US$ 5.7 Billion by 2025
The Global Myelodysplastic Syndrome Treatment Market was valued at US$ 2,213.2 million in 2017 and is projected to expand at a CAGR of 12.7% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing incidence of the bone marrow disorders and cytogenetic abnormalities expected to be the major factor driving growth of the global myelodysplastic syndrome treatment market over the foreseeable future.
Myelodysplastic syndrome…
Myelodysplastic Syndrome Market: Product Innovation to Underscore Lucrative Grow …
Growing prevalence of cancer fuels demand for treatments such as radiation and chemotherapy. Treatment of the cancer has led to increasing prevalence myelodysplastic syndrome globally. The myelodysplastic syndrome is mainly linked to various risk factors such as radiation and chemicals. Market Research Hub research report offers insights on the “Myelodysplastic Syndrome - Epidemiology Forecast to 2025”. This report offers a detailed insight that offer details and important opinions in the Myelodysplastic…
Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025
"The Report Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
DelveInsights Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for…
